Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder.

MLA

Cha, Danielle S., et al. “Brexpiprazole as an Augmentation Agent to Antidepressants in Treatment Resistant Major Depressive Disorder.” Expert Review of Neurotherapeutics, vol. 19, no. 9, Sept. 2019, pp. 777–83. EBSCOhost, https://doi.org/10.1080/14737175.2019.1653759.

APA

Cha, D. S., Luo, X., Ahmed, J., Becirovic, L., Cha, R. H., & McIntyre, R. S. (2019). Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Review of Neurotherapeutics, 19(9), 777–783. https://doi.org/10.1080/14737175.2019.1653759

Chicago

Cha, Danielle S, Xinyi Luo, Juhie Ahmed, Larissa Becirovic, Rebekah H Cha, and Roger S McIntyre. 2019. “Brexpiprazole as an Augmentation Agent to Antidepressants in Treatment Resistant Major Depressive Disorder.” Expert Review of Neurotherapeutics 19 (9): 777–83. doi:10.1080/14737175.2019.1653759.